MSH2 and breast cancer: However, the study by Poplawski et al. reported conflicting results, attributing 322Gly variant to BC susceptibility41 while the meta‐analysis by Zhang et al. finds no observable association between hMSH2 rs4987188 polymorphism and BC.42